Glenmark gets India approval for favipiravir as COVID-19 treatment
June 19, 2020 at 09:54 AM EDT
Glenmark Pharmaceuticals Ltd said on Friday it had received an approval from India's drugs regulator to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 patients in the country.